Skip to main content
Premium Trial:

Request an Annual Quote

Opko Acquires Brazilian Pharma Company, Clearing Way for Launch of 4kscore Prostate Cancer Test

Premium

Opko Health said it has completed the acquisition of the Brazilian pharmaceutical firm Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos.

The acquisition will allow Opko to commercialize its Opko 4kscore prostate cancer diagnostic in Brazil as a laboratory-developed test while it obtains Brazilian approval for an in vitro diagnostic version of the product.

The 4kscore test uses two protein biomarkers in the kallikrein family along with prostate-specific antigen for early detection of prostate cancer. Opko licensed the two markers from Finnish biotech firm Artic Partners in January 2012 (PM 1/30/2012).

According to Opko, use of the panel could potentially eliminate more than 50 percent of unnecessary prostate biopsies by improving on the specificity of existing PSA tests.

In October, Opko started European sales of the test, marketing it through its partner International Health Technology (PM 10/5/2012). It is also planning to launch the test in the US as a laboratory-developed test in the near future.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.